Amyloid beta accumulation in HIV‐1‐infected brain: The role of the blood brain barrier
Year: 2012
Type: review
Abstract: In recent years, we face an increase in the aging of the HIV-1-infected population, which is not only due to effective antiretroviral therapy but also to new infections among older people. Even with the use of the antiretroviral therapy, HIV-associated neurocognitive disorders represent an increasing problem as the HIV-1-infected population ages. Increased amyloid beta (Aβ) deposition is characteristic of HIV-1-infected brains, and it has been hypothesized that brain vascular dysfunction contributes to this phenomenon, with a critical role suggested for the blood-brain barrier in brain Aβ homeostasis. This review will describe the mechanisms by which the blood-brain barrier may contribute to brain Aβ accumulation, and our findings in the context of HIV-1 infection will be discussed.
Source: IUBMB Life
DOI: 10.1002/iub.1106
Authors: Ibolya E. András, Michal Toborek
Institution: University of Miami
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Funders: University of Miami, National Institutes of Health, Miami Center for AIDS Research, District of Columbia Developmental Center for AIDS Research, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke
Awards: Exercise as a novel strategy to target methamphetamine-induced cerebrovascular to, Tat-mediated brain endothelial cell dysfunction, Implications of caveolae in Tat signaling and integrity of brain endothelium, Interplay between cArt, HIV, and amyloid at the blood-brain barrier., HIV-1 and amyloid beta interactions at the blood-brain barrier, Miami Center for AIDS Research
OpenAlex ID: W2091277662
